These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1890206)

  • 1. Treatment of acute myeloid leukaemia in a renal allograft recipient: implications of cyclosporin immunosuppressive treatment.
    Cuthbert RJ; Russell NH; Jones PA; Morgan AG
    J Clin Pathol; 1991 Aug; 44(8):693-5. PubMed ID: 1890206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
    Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
    Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory failure during induction chemotherapy for acute myelomonocytic leukaemia (FAB M4Eo) with ara-C and all-trans retinoic acid.
    Lester WA; Hull DR; Fegan CD; Morris TC
    Br J Haematol; 2000 Jun; 109(4):847-50. PubMed ID: 10929040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient.
    Gorschlüter M; Glasmacher A; Risse F; Klein B; Klehr HU; Mezger J
    Nephrol Dial Transplant; 1997 Mar; 12(3):593-5. PubMed ID: 9075151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
    Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
    Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myelomonocytic leukaemia and 48,XXY, +8 chromosome anomalies.
    Ng JP; Challinor P; Strevens MJ
    Clin Lab Haematol; 1992; 14(1):81-5. PubMed ID: 1600697
    [No Abstract]   [Full Text] [Related]  

  • 7. Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
    Büchner T; Hiddemann W; Blasius S; Koch P; Maschmeyer G; Tirier C; Sodomann H; Kuse R; Thiel E; Ludwig WD
    Haematol Blood Transfus; 1990; 33():261-6. PubMed ID: 2182419
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
    Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ
    Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia.
    Sonneveld P; Nooter K
    Br J Haematol; 1990 Jun; 75(2):208-11. PubMed ID: 2372507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow fibre content in acute myeloid leukaemia before and after treatment.
    Islam A; Catovsky D; Goldman JM; Galton DA
    J Clin Pathol; 1984 Nov; 37(11):1259-63. PubMed ID: 6594351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA.
    Petti MC; Mandelli F; Vegna ML; Broccia G; Carotenuto M; De Rosa F; Di Marco P; Di Raimondo F; Fioritoni G; Leone G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():119-20. PubMed ID: 2653486
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
    Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
    Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
    Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
    J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
    Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute myelocytic leukemia with a daunorubicin-cytarabine-6 thioguanine regimen without maintenance therapy.
    Freund M; Poliwoda H; Bodenstein H; Eisert R
    Onkologie; 1985 Jun; 8(3):150-2. PubMed ID: 3895097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute leukemia and pregnancy. Case report.
    Veneri D; Todeschini G; Pizzolo G; Franchini M; Ambrosetti A; Vassanelli A; Bressan F; Diani F
    Clin Exp Obstet Gynecol; 1996; 23(2):112-5. PubMed ID: 8737625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
    Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM
    Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.